Audentes Therapeutics

Audentes Therapeutics

World Rank (Aug-2026)
10512
Market Cap (Aug-2026)
0.758 Billion USD
World Rank (Jan-05-2024)
4,519
World Rank (Jul-30-2023)
4,519
World Rank (Jan-07-2022)
4,519
World Rank (Jan-01-2021)
4,519
Headquarters Country
USA
Employee Count
250
Employee Count as of Date
As of 2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-134 Million USD
Annual Net Income in USD
-129 Million USD
Annual Results for Period Ending
For year ending December-2018
Total Assets in USD
473 Million USD
Total Liabilities in USD
30 Million USD
Total Equity in USD
443 Million USD
Balance Sheet for Period Ending
As of December-2018
Business Sector
Healthcare
Biotechnology
Technology
HealthCare Products
Company Profile

Audentes Therapeutics is a Genetic Medicines company. The company overall incidence is estimated to be approximately 1 in 40,000 births although frequency and disease progression varies with age of onset, ethnicity and geography. The headquarters is in USA.

Astellas completes acquision of Audentes in Jan 2020 for approximately 3 Billion USD.

IPO Year
2016
Stock Exchange
Nasdaq
Frankfurt

Share